Levent Mutlu

ORCID: 0009-0000-5861-9277 · 8 papers in corpus
observational 2022
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100913

OBJECTIVE: To examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease. METHODS: A retro…

lab-animal 2017
Oncotarget ·doi:10.18632/oncotarget.16889

Endometriosis is an inflammatory gynecological disorder among reproductive-aged women caused by the engraftment and proliferation of endometrial cells outside the uterus, most commonly in the pelvis. It is thought that the disease arises pr…

lab-animal 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.05.020

OBJECTIVE: To evaluate associations between aromatase inhibitor (AI) treatment and let-7-family microRNA expression in endometriosis. DESIGN: In vitro study with the use of Ishikawa cells and human endometrial stromal cells (HESCs) obtaine…

lab-animal 2015
Stem cell research ·doi:10.1016/j.scr.2015.04.004

Bone marrow derived cells engraft to the uterine endometrium and contribute to endometriosis. The mechanism by which these cells are mobilized and directed to the endometrium has not been previously characterized. We demonstrate that human …

2015
·doi:10.1016/j.fertnstert.2015.07.210
other 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.02.013

OBJECTIVE: To evaluate whether microRNAs (miRNAs) associated with endometriosis are detectable in the circulation and could serve as potential noninvasive biomarkers for endometriosis. DESIGN: Case-control study. SETTING: University hospi…

2015
·doi:10.1016/j.fertnstert.2015.07.211
review 2015
Biology of reproduction ·doi:10.1095/biolreprod.114.126771

Stem cell therapies have opened new frontiers in medicine with the possibility of regenerating lost or damaged cells. Embryonic stem cells, induced pluripotent stem cells, hematopoietic stem cells, and mesenchymal stem cells have been used …